Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis.
Grayston
J T
JT
Department of Epidemiology, University of Washington, Seattle, WA, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000382:microbiology* / Q000517:prevention & control*; D017963:Azithromycin / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000150:complications / Q000276:immunology / Q000517:prevention & control; D016993:Chlamydophila pneumoniae / Q000276:immunology / Q000472:pathogenicity*; D002986:Clinical Trials as Topic / Q000379:methods; D003131:Combined Modality Therapy; D006801:Humans; D012107:Research Design; D014612:Vaccines / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014612:Vaccines; D017963:Azithromycin